Digital allies making diabetes less invasive and more controllable

Answer: For those living with diabetes, every day is made up of constant choices and attention: checking blood sugar, planning meals, taking medication, dosing insulin, interpreting the body's signals. In recent years, however, the management of the disease has changed profoundly, thanks to the introduction of technologies that have revolutionised the daily lives of millions of people. These are not just more precise tools, but real digital allies that make diabetes less invasive and more controllable. One of the most significant innovations is the continuous blood glucose monitoring (CGM) systems, small sensors that, applied under the skin, provide real-time blood glucose values, allowing constant monitoring without the need to prick oneself several times a day. These devices not only record data, but also send alarms in the event of hypoglycaemia or hyperglycaemia, helping the patient to intervene promptly and prevent complications. Data can be synchronised with smartphones, dedicated apps and even shared remotely with one's doctor or family members, thus improving therapeutic adherence and support.

In parallel, insulin pumps have also evolved: small wearable devices that release insulin continuously throughout the day, replicating the physiological behaviour of the pancreas. The most recent models are able to interact directly with CGM sensors, resulting in 'closed loop hybrid' or 'artificial pancreas' systems, capable of automatically adjusting the insulin dosage based on detected blood glucose values. This automatism significantly reduces the daily effort required of the person with diabetes, improves metabolic control and limits the risk of serious episodes, such as hypoglycaemic crises or ketoacidosis. Apps are also playing an increasingly central role in managing the disease. There are digital tools that help monitor blood glucose trends, calculate carbohydrates, organise meals, and even predict future glycaemic changes thanks to artificial intelligence. These apps become, especially for younger people, a natural extension of their connected lives, and transform diabetes management into an easier and less medicalised activity.

Telemedicine accelerated significantly during the pandemic, but has also proved its value in the long run. It allows remote checks, video call consultations, and the sending and reading of blood glucose data in real time. In particular, it is an invaluable tool for those who live far from specialised centres or who find it difficult to visit clinics frequently. Technology, however, is not standing still. Long-lasting implantable sensors are being developed, intelligent insulin delivery systems, smart insulins that can 'switch on' or 'switch off' according to blood glucose trends, bio-engineered pancreatic prostheses via 3D printing, and even nanotechnologies that will allow even more precise and personalised glycaemic control. 3D printers, for instance, are revolutionising the field of regenerative medicine and device customisation: in the field of diabetes, work is being done on the possibility of printing bio-compatible pancreatic tissue, or even artificial mini-pancreas capable of producing insulin. This is still an experimental but promising prospect that could in the future offer a 'tailor-made cure' for certain forms of diabetes.

Implantable sensors, which are already a reality, are an evolution of continuous blood glucose monitoring systems: unlike traditional devices, which are applied to the skin and have a limited lifespan, these sensors can be implanted under the skin and remain active for months, reducing the need for frequent changes

Finally, nanotechnology is opening up new possibilities in both early diagnosis and targeted drug delivery. For example, intelligent nanoparticles capable of transporting insulin or other active ingredients in a selective and controlled manner, releasing them only when and where they are needed, reducing side effects and improving therapeutic efficacy. Other applications include nanoscale sensors capable of detecting minute changes in glucose levels or inflammatory markers, enabling ultra-precise monitoring.